We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




IBM Debuts Watson Health Cognitive Imaging Solution

By MedImaging International staff writers
Posted on 16 Mar 2017
Print article
Image: The Watson Imaging Clinical Review (WICR) is designed to help healthcare providers identify patients that require urgent attention (Photo courtesy of IBM).
Image: The Watson Imaging Clinical Review (WICR) is designed to help healthcare providers identify patients that require urgent attention (Photo courtesy of IBM).
IBM has launched the IBM Watson Imaging Clinical Review (WICR), the first cognitive imaging offering from Watson Health that is designed to help healthcare providers identify patients that require urgent attention.

IBM Watson Imaging Clinical Review is a cognitive "peer-review" tool designed to enable reconciliation of discrepancies between a patient’s clinical diagnosis and administrative records, ultimately providing a more accurate patient record. Essentially, it uses cognitive text analytics to read both structured and unstructured information in cardiology medical reports, combines it with a variety of data from other sources, and extracts the relevant information needed to verify that key data, including the diagnosis, is accurately reflected throughout the electronic medical record (EMR).

It subsequently compares the clinical data with the EMR problem list and medical coding to empower users with accurate information. The first application introduced is designed to identify cardiovascular disease (CVD) patients suffering from aortic stenosis, a debilitating condition that causes shortness of breath, tiredness, and chest pain. IBM plans to supplement the release of the initial offering with nine other cardiovascular conditions, such as myocardial infarction (MI), valve disorders, cardiomyopathy, and deep vein thrombosis (DVT).

“Apart from identifying patients who might need follow-up care, Watson will look across patient populations to figure out similar patients who could benefit from follow-up visits, even if their ultrasounds or other images weren't analyzed by Watson,” said Anne Le Grand, vice president of imaging for Watson Health. “Then, Watson will move into predictive care, helping to recommend treatment for patients who could be at risk based on the computer's AI analysis. The response is twofold: improving the quality of diagnosis and the consistency of diagnosis.”

“If you have an ultrasound image of a heart, the quality [of care] could be affected by how good the technology is and also by variations in how different physicians may interpret those images,” said cardiologist Jaime Murillo, MD, of Sentara Healthcare (Norfolk, VA, USA). “With Watson, we're looking at standardizing and improving accuracy of diagnostic interpretations that result in better patient care and more accuracy.”

Watson--named after Thomas Watson, the first president of IBM--incorporates a technology called Deep Question and Answer (DeepQA) that allows it to analyze human language and quickly process huge amounts of information. The same technology can be applied to help Watson sift through the equivalent of about a million books or roughly 200 million pages of data, analyze the information, and provide an answer in less than three seconds.

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Color Doppler Ultrasound System
DRE Crystal 4PX
Thyroid Shield
Standard Thyroid Shield
Oncology Information System
RayCare

Print article
Radcal

Channels

MRI

view channel
Image: The emerging role of MRI alongside PSA testing is redefining prostate cancer diagnostics (Photo courtesy of 123RF)

Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients

Prostate cancer is a leading health concern globally, consistently being one of the most common types of cancer among men and a major cause of cancer-related deaths. In the United States, it is the most... Read more

Nuclear Medicine

view channel
Image: The new SPECT/CT technique demonstrated impressive biomarker identification (Journal of Nuclear Medicine: doi.org/10.2967/jnumed.123.267189)

New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access

The development of lead-212 (212Pb)-PSMA–based targeted alpha therapy (TAT) is garnering significant interest in treating patients with metastatic castration-resistant prostate cancer. The imaging of 212Pb,... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.